21/12/2014 04:56:27 Free Membership Login

   

Alnylam Pharmaceuticals, Inc.

Visual Financials
Company Name: Alnylam Pharmaceuticals, Inc.
Ticker Symbol: ALNY
WWW Address: http://www.alnylam.com
CEO: John Maraganore
No. of Employees: 129
Common Issue Type: CS
Business Description:Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 100.91 Up 1.5 100.69 140.0 98.54 101.97 97.77 1408360
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 7,763.1 76.9 0.00 -1.45 0.00 0.0 0.0 112.57 - 47.03
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close100.73$
PE Ratio - LTM0.0
Market Capitalisation7,763.1mil
Latest Shares Outstanding76.9mil
Earnings pS (EPS)-1.45$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float48.0mil
Float as % of Shares Outstanding0.6%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue2.40%
Gross Profit Margin100.0%
EBITDA Margin-175.4%
Pre-Tax Profit Margin0.0%
Assets Turnover13.3%
Return on Assets (ROA)-25.2%
Return on Equity (ROE)-44.1%
Return on Capital Invested (ROCI)-44.1%
Current Ratio4.7
Leverage Ratio (Assets/Equity)1.6
Interest Cover
Total Debt/Equity (Gearing Ratio)
LT Debt/Total Capital0.0%
Working Capital pS2.60$
Cash pS0.00$
Book-Value pS11.76$
Tangible Book-Value pS3.51$
Cash Flow pS-2.14$
Free Cash Flow pS-2.58$
KEY FIGURES (LTM): Price info
Price/Book Ratio8.57
Price/Tangible Book Ratio0.00
Price/Cash Flow-47.2
Price/Free Cash Flow-39.1
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---111.4974.0456-1
4 Weeks101.9797.7797.77111.4974.049728
13 Weeks100.73100.73140309587.88112.5710028
26 Weeks1403095111.49111.4989.56112.5710011
52 Weeks90.0490.0491.72111.4947.039411
YTD47.0347.03-111.4947.03350
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
72.3772.3777.7677.76111.495.875.87
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue1197145276545517654551
Income119714521197145246053170
Dividend460531708909880589098805
Capital Spending188790430NA188790430
R&D9529796NA9529796
Normalized Inc.46053170NA46053170
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %362323
Earnings %464643
EPS %164171171
EPS $43148148
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio420530000
Quick Ratio (Acid Test)166502000
Liquidity Ratio (Cash)0.00
Receivables Turnover32696000
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS270347000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)5896000
Debt Ratio150183000
Total Debt/Equity (Gearing Ratio)No
LT Debt/Equity
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities150183000
Interest Cover-41316000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM89,513,957.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-21.07
Dividend Yield4072707
Price/Tangible Book Ratio - LTM159
Price/Book Ratio - LTM748322
Price/Cash Flow Ratio4.7
Price/Free Cash Flow Ratio - LTM159
Price/Sales Ratio-2.00
P/E Ratio (1 month ago) - LTM89513957
P/E Ratio (26 weeks ago) - LTM148330973
P/E Ratio (52 weeks ago) - LTM148330973
5-Y High P/E Ratio189325618
5-Y Low P/E Ratio185391072
5-Y Average P/E Ratio716004
Current P/E Ratio as % of 5-Y Average P/E716004
P/E as % of Industry Group598,572.0
P/E as % of Sector Segment598,572.0
Current 12 Month Normalized P/E Ratio - LTM695,868.0
PER SHARE FIGURES
LT Debt pS
Current Liabilities pS
Tangible Book Value pS - LTM4.7
Book Value pS - LTM748322
Capital Invested pS0.00
Cash pS - LTM51084
Cash Flow pS - LTM2.69
Free Cash Flow pS - LTM2.69
Earnings pS (EPS)972
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-41316000
Net Profit Margin - 5YEAR AVRG.2014-10-31
Equity Productivity0.00
Return on Equity (ROE)270347000
Return on Equity (ROE) - 5YEAR AVRG.7749268695
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-99
Assets Productivity5,896,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.7749268695
Gross Profit Margin598572
Gross Profit Margin - 5YEAR AVRG.-99
EBITDA Margin - LTM708510
EBIT Margin - LTM598572
Pre-Tax Profit Margin16448000
Pre-Tax Profit Margin - 5YEAR AVRG.76931090
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle53,864,248
Revenue per Employee
Net Income per Employee
Average Collection Period
Receivables Turnover32696000
Day's Inventory Turnover Ratio53864000
Inventory Turnover32696000
Inventory/Sales
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover5896000
Revenue per $ Cash14160000
Revenue per $ Plant14160000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.76931090
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq alny141221 04:56